Young boys look onwards at the class 2 and class 6 level school children as they parade through the streets of Odumase, Eastern Region, chanting and singing about malaria prevention. | 2016 Sarah Hoibak/VectorWorks, Courtesy of Photoshare


Accelerating the development and uptake of the most needed drug formulations for children

Limited treatment options and sub-optimal formulations have contributed to poor adherence and outcomes for children living with HIV as well as other diseases that impact the lives of children living in resource limited settings.

The Global Accelerator for Paediatric Formulations (GAP-f) aims to promote a faster, more efficient and more focused approach to paediatric formulation development. It is a collaborative framework that can help get better paediatric products quicker and cheaper by prioritizing products, streamlining the generation of clinical evidence, incentivizing manufacturers, accelerating product development and introduction, and coordinating procurement. The GAP-f formalizes collaboration across sectors to ensure accelerated development and uptake of the most needed drugs and formulations for children.